Exploring the Association Between Gender Affirmation and PrEP use Among Transgender Women in New York City
Related Experiment Video
Updated: Aug 16, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Alexis V Rivera1, Jasmine M Lopez2, Sarah L Braunstein3
1Bureau of Hepatitis, HIV, and STI, New York City Department of Health and Mental Hygiene, 42-09 28th Street, CN-44, 11101, Queens, NY, USA. arivera6@health.nyc.gov.
Abstract:
Black and Hispanic/Latina transgender women are inequitably impacted by HIV; yet gaps in PrEP use exist. Among a sample of mostly Black and Hispanic/Latina transgender women in New York City, we aim to examine whether PrEP use was associated with gender affirmation and the use of gender-affirming health services. We found that PrEP use was more prevalent among those who used hormone therapy and those who had a provider they were comfortable speaking to about gender-related issues. In separate models, these associations were attenuated when adjusting for race/ethnicity, with those who use hormones being marginally more likely to report PrEP use and with Hispanic/Latina transgender women being more likely to have used PrEP, compared to Black transgender women. We found evidence of a potential association between medical gender affirmation and PrEP use. More research is needed to explore the social and structural contexts that are influenced by race/ethnicity that may serve to prevent PrEP uptake.

